Armata Pharmaceuticals (ARMP) Enterprise Value (2016 - 2018)
Historic Enterprise Value for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to -$13.4 million.
- Armata Pharmaceuticals' Enterprise Value fell 7337.22% to -$13.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$13.4 million, marking a year-over-year decrease of 7337.22%. This contributed to the annual value of -$5.1 million for FY2017, which is 0.0% changed from last year.
- As of Q3 2018, Armata Pharmaceuticals' Enterprise Value stood at -$13.4 million, which was down 7337.22% from -$15.4 million recorded in Q2 2018.
- Armata Pharmaceuticals' Enterprise Value's 5-year high stood at -$2.2 million during Q1 2017, with a 5-year trough of -$16.6 million in Q1 2015.
- For the 5-year period, Armata Pharmaceuticals' Enterprise Value averaged around -$9.5 million, with its median value being -$9.0 million (2017).
- The largest annual percentage gain for Armata Pharmaceuticals' Enterprise Value in the last 5 years was 6766.89% (2014), contrasted with its biggest fall of 218581.36% (2014).
- Quarter analysis of 5 years shows Armata Pharmaceuticals' Enterprise Value stood at -$6.6 million in 2014, then crashed by 42.38% to -$9.4 million in 2015, then surged by 45.23% to -$5.1 million in 2016, then changed by 0.0% to -$5.1 million in 2017, then plummeted by 160.97% to -$13.4 million in 2018.
- Its last three reported values are -$13.4 million in Q3 2018, -$15.4 million for Q2 2018, and -$8.2 million during Q1 2018.